Home Equities Score Protalix BioTherapeutics, Inc. (PLX) stock is tumbling today: Why is it so?

Protalix BioTherapeutics, Inc. (PLX) stock is tumbling today: Why is it so?

Shares of the Protalix BioTherapeutics, Inc. (PLX)  stock were tumbling today following the release of the updated data related to the clinical development of PRX-102 for the treatment of patients suffering from Fabry Disease. PLX stock price saw a downtrend of  14.77% to drop at $2.54 a share as of this writing. At the previous closing, the per-share price of PLX stock dropped by 1.97%. Let’s discuss more about the PLX stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now.

PRX-102 Development Program Update:

The PRX-102 Development program is the 24-month BALANCE study of the efficacy of 1 mg/kg dose of PRX–102 against agalsidase beta (Fabrazyme®) in patients suffering from Fabry disease.78 patients were enrolled in this study. Two analysis sets were defined for this study. One is Intention to Treat (ITT) which consists of 77 patients who got at least one dose and the second is Per Protocol (PP) which consists of 74 patients who have undergone 12 months of treatment without the violation of major protocol.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

According to the topline results, the lower limit of the confidence interval for the mean difference between the active compactor and the new drug was below the prespecified non-inferiority margin for the ITT analysis set and above the PP analysis set. Treatment emergent adverse effects resulted in the discontinued participation of two patients, however, no deaths were reported.

Financial Results of PLX stock:

On May 14, 2021, Protalix did announce the first quarter of 2021 financial results according to which $4.5million revenue from the selling of goods was reported, decreased by $0.5 million in the same quarter of the previous year.A 59% decrease was observed in the licenses and R&D revenue of $6.8 million for the first quarter of 2021 compared to the same quarter of the previous year.

PLX stock spent $7.1 million in research and development expenses and $3.1 million for the general, selling, and administrative expenses in the first quarter of 2021 while these expenses were $10.3 million and $3.2 million respectively for the respective quarter of the previous year.

Balance Sheet:

As of March 31, 2021, PLX stock had cash and cash equivalents of $19.83 million as compared to $18.27 million by the end of December 2020.$8.8 million gross proceeds were raised from the offering of common stock by Protalix stock under the ATM program and $40.2 million gross proceeds were raised through the public offering of its common stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now.

Wrap Up:

PLX stock is continuing the downtrend as far as market sentiment is concerned with its recent release of updated clinical data of PRX-102.In short, deep fundamental, as well as technical analysis, is necessary before adding PLX stock to the portfolio.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Ocugen Inc. (OCGN) stock surged during pre-market trading session. Here’s what you should know?

Ocugen Inc. (NASDAQ: OCGN) stock gained by 2.12% at last close while the OCGN stock price soars during pre-market trading by 4.95%. Ocugen, Inc....

Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?

Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%....

Unique Fabricating Inc. (UFAB) stock gains during pre-market trading. Let’s figure out why?

Unique Fabricating Inc. (NASDAQ: UFAB) stock declined by 1.21% at the last close while the UFAB stock price tends to rise by 40.67% in...

Torchlight Energy Resources Inc. (TRCH) stock soars during after-hour session. Let’s see why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 14.74% at last close while the TRCH stock price further rose by 16.48% in the...

Orphazyme A/S (ORPH) stock is Popping High in Pre-Market today: Here’s to know Why?

Shares of Orphazyme A/S (ORPH) stock were popping high in the pre-market today on June 14, 2021, after dropping with more than half of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam